Abstract | OBJECTIVE: DESIGN: Case report. SETTING: PATIENT: INTERVENTIONS: MEASUREMENTS AND MAIN RESULTS: CONCLUSIONS: High-dose propofol should be avoided and alternative agents should be instituted for sedation and intracranial pressure management. The use of catecholamine infusions to maintain cerebral perfusion pressure in the setting of a high-dose propofol infusion may be pharmacologically unsound and may be a triggering factor for propofol infusion syndrome. Identification of the syndrome and discontinuation of propofol resulted in complete reversal of symptoms in the case described.
|
Authors | Stephanie Mallow Corbett, Jesse Moore, Jill A Rebuck, Frederick B Rogers, Christopher M Greene |
Journal | Critical care medicine
(Crit Care Med)
Vol. 34
Issue 9
Pg. 2479-83
(Sep 2006)
ISSN: 0090-3493 [Print] United States |
PMID | 16791112
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Anesthetics, Intravenous
- Vasoconstrictor Agents
- Norepinephrine
- Propofol
|
Topics |
- Acidosis, Lactic
(chemically induced)
- Adult
- Anesthetics, Intravenous
(administration & dosage, adverse effects)
- Brain Injuries
(drug therapy)
- Drug Therapy, Combination
- Humans
- Infusions, Intravenous
- Intensive Care Units
- Intracranial Hypertension
(prevention & control)
- Male
- Norepinephrine
(administration & dosage, adverse effects)
- Propofol
(administration & dosage, adverse effects)
- Vasoconstrictor Agents
(administration & dosage, adverse effects, therapeutic use)
|